what are the factors affecting posology - An Overview
Nonetheless, There exists a minority of cases wherever the therapy of EID utilizing the ICOC chelation protocol involving DF or L1 or their blend is probably not feasible due to low tolerability or poisonous Uncomfortable side effects for instance allergic reactions during parenteral infusion of DF or toxicity like L1 agranulocytosis (Table 1). In